Home/Filings/4/0001562180-25-003157
4//SEC Filing

DWEK RAYMOND 4

Accession 0001562180-25-003157

CIK 0001082554other

Filed

Apr 14, 8:00 PM ET

Accepted

Apr 15, 4:28 PM ET

Size

8.6 KB

Accession

0001562180-25-003157

Insider Transaction Report

Form 4
Period: 2025-04-14
DWEK RAYMOND
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2025-04-14$175.43/sh+3,000$526,2904,750 total
  • Sale

    Common Stock

    2025-04-14$285.16/sh3,000$855,4801,750 total
  • Exercise/Conversion

    Stock Option

    2025-04-143,0003,000 total
    Exercise: $175.43From: 2016-06-26Exp: 2025-06-26Common Stock (3,000 underlying)
Footnotes (1)
  • [F1]This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 2, 2024.

Issuer

UNITED THERAPEUTICS Corp

CIK 0001082554

Entity typeother

Related Parties

1
  • filerCIK 0001231617

Filing Metadata

Form type
4
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 4:28 PM ET
Size
8.6 KB